Turk Kardiyol Dern Ars. 2023; 51(7): 470-477 | DOI: 10.5543/tkda.2023.78074

The Usefulness of the TAPSE/sPAP Ratio for Predicting Survival in Medically Treated Chronic Thromboembolic Pulmonary Hypertension

Ayşe Çolak¹, Zeynep Kumral¹, Mehmet Kış¹, Bihter Şentürk¹, Dilek Sezgin², Gökçen Ömeroğlu Şimşek³, Can Sevinç³, Bahri Akdeniz^1
1Department of Cardiology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye
²Department of Nursing, Dokuz Eylül University Faculty of Nursing, İzmir, Türkiye
³Department of Pulmonology, Dokuz Eylül University Faculty of Medicine, İzmir, Türkiye

OBJECTIVE
The ventriculoarterial uncoupling has been linked with unfavorable results as measured noninvasively by tricuspid annular plane systolic excursion divided by systolic pulmonary artery pressure (TAPSE/sPAP). However, its prognostic importance in chronic thromboembolic pulmonary hypertension (CTEPH) is limited. Thus, we determine the effect of the TAPSE/sPAP ratio on outcomes and predictors of all-cause mortality in these patients.


METHODS
We analyzed 56 subjects with medically treated CTEPH. Two-dimensional echocardiographic examination and right heart catheterization findings were recorded from the hospital database. Baseline New York Heart Association functional class (NYHA-FC), 6-min walk distance (6MWD), and brain natriuretic peptide (BNP) test results were recorded.


RESULTS
The median age was 65.5 years. Over a median follow-up time of 27 months, 29 (51.8%) patients died. BNP values were higher (P = 0.008), 6MWD values were lower (P = 0.004), and NHYA-FC (P = 0.0001) was worse in the non-survivor group. TAPSE (P = 0.0001) and TAPSE/sPAP ratio (P = 0.001) were significantly lower and pulmonary vascular resistance (PVR) was higher in the non-survivor group (P = 0.03). The best cut-off value for the TAPSE/sPAP ratio for predicting mortality was 0.20 mm/mmHg and the survival rates were significantly lower in the TAPSE/sPAP ratio ≤0.20 group (log-rank P = 0.012). 6MWD (P = 0.005), NHYA-FC III-IV (P = 0.0001), TAPSE/sPAP ratio ≤0.20 (P = 0.017), PVR (P = 0.008), and TAPSE/sPAP ratio ≤0.20 combined with NYHA-FC III-IV (P = 0.0001) were significant determinants and TAPSE/sPAP ratio ≤0.20 combined with NYHA-FC III-IV was the only independent predictor of mortality (P = 0.003).


CONCLUSION
Medically treated CTEPH patients with a TAPSE/sPAP ratio ≤0.20 had lower survival rates. TAPSE/sPAP ratio≤0.20 combined with NYHA-FC III-IV was the independent predictor of poor prognosis.

Keywords: Chronic thromboembolic pulmonary hypertension, mortality, tricuspid annular plane systolic excursion divided by systolic pulmonary artery pressure ratio

---

CITE